{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:47:50Z","timestamp":1787500070956,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A chronic inflammatory condition of the colon called ulcerative colitis (UC) is characterized by mucosal surface irritation that extends from the rectum to the near proximal colon portions. The rationale of this work was to conclude if dulaglutide (Dula) could protect rats from developing colitis caused by exposure to acetic acid (AA). Rats were randomly divided into seven groups (each with eight rats): Normal control, Dula control, AA (received 2 milliliters of 3% v\/v AA through the rectum), Sulfasalazine (SLZ); given SLZ (100 mg\/kg) orally from day 11 to day 21 then AA intrarectally on day 22 and Dula groups ( pretreated with 50, 100 or 150 \u03bcg\/kg subcutaneous injection of Dula - once weekly for three weeks and AA on day 22 to induce ulcerative colitis, colon tissues and blood samples were taken on day 23. By generating colonic histological deviations such as inflammatory processes, goblet cell death, glandular hyperplasia, and mucosa ulcers, Dula dropped AA-induced colitis. Additionally, these modifications diminished blood lactate dehydrogenase (LDH), C-reactive protein (CRP), colon weight, and the weight\/length ratio of the colon. In addition, Dula decreased the oxidative stress biomarker malondialdehyde (MDA) and increased the antioxidant enzymes (total antioxidant capacity (TAC), reduced glutathione (GSH), and superoxide dismutase (SOD) concentrations). Dula also significantly reduced the expression of transforming growth factor-1 (TGF-\u03b21), phosphatidylinositol-3-kinase (PI3K), protein kinase B (AKT) signaling pathway, and the inflammatory cytokines: nuclear factor kappa B (NF-\u03baB), interleukin-6 (IL-6), and interferon-\u03b3 (IFN-\u03b3) in colonic cellular structures. In addition, Dula enforced the levels of glucagon-like peptide-1 (GLP-1) and trefoil factor-3 (TFF-3) that were crucial to intestinal mucosa regeneration and healing of wounds. By modulating TGF-\u03b21 in conjunction with other inflammatory pathways like PI3K\/AKT and NF-\u03baB, regulating the oxidant\/antioxidant balance, and improving the integrity of the intestinal barrier, Dula prevented AA-induced colitis in rats.<\/jats:p>","DOI":"10.1007\/s00210-024-03631-5","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T02:35:44Z","timestamp":1732329344000},"page":"5611-5628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-\u03b2\/PI3K\/NF-\u03baB signaling pathway"],"prefix":"10.1007","volume":"398","author":[{"given":"Raghda N. El","family":"Mahdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar G.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally E.","family":"Abu-Risha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa E.","family":"Abdelmageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"3631_CR1","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.3748\/wjg.v20.i12.3223","volume":"20","author":"L Aamann","year":"2014","unstructured":"Aamann L, Vestergaard EM, Gr\u00f8nb\u00e6k H (2014) Trefoil factors in inflammatory bowel disease. World J Gastroenterol 20:3223\u20133230","journal-title":"World J Gastroenterol"},{"key":"3631_CR2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-physiol-021115-105447","volume":"79","author":"E Aihara","year":"2017","unstructured":"Aihara E, Engevik KA, Montrose MH (2017) Trefoil factor peptides and gastrointestinal function. Annu Rev Physiol 79:357\u2013380","journal-title":"Annu Rev Physiol"},{"key":"3631_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.33594\/000000504","volume":"56","author":"M Ala","year":"2022","unstructured":"Ala M, Jafari RM, Nematian H, Shadboorestan A, Dehpour AR (2022) Sodium selenite modulates IDO1\/Kynurenine, TLR4, NF-\u03baB and Bcl2\/Bax pathway and mitigates acetic acid-induced colitis in rat. Cell Physiol Biochem 56:24\u201335","journal-title":"Cell Physiol Biochem"},{"key":"3631_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/JIR.S230818","volume":"12","author":"A Al-Dwairi","year":"2019","unstructured":"Al-Dwairi A, Alqudah TE, Al-Shboul O, Alqudah M, Mustafa AG, Alfaqih MA (2019) Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate\/nuclear factor-\u03baB pathway in vitro [Corrigendum]. Journal of Inflammation Research 12:267\u2013268","journal-title":"Journal of Inflammation Research"},{"key":"3631_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pharep.2016.11.002","volume":"69","author":"AA Ali","year":"2017","unstructured":"Ali AA, Abd Al Haleem EN, Khaleel SA, Sallam AS (2017) Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats. Pharmacol Rep 69:268\u2013275","journal-title":"Pharmacol Rep"},{"key":"3631_CR6","first-page":"1487","volume":"25","author":"AMEA Ali","year":"2022","unstructured":"Ali AMEA, Osman HM, Zaki AM, Shaker O, Elsayed AM, Abdelwahed MY, Mohammed RA (2022) Reno-protective effects of GLP-1 receptor agonist and anti-platelets in experimentally induced diabetic kidney disease in male albino rats. Iranian Journal of Basic Medical Sciences 25:1487","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"3631_CR7","first-page":"659","volume":"13","author":"AN Anbazhagan","year":"2017","unstructured":"Anbazhagan AN, Thaqi M, Priyamvada S, Jayawardena D, Kumar A, Gujral T, Chatterjee I, Mugarza E, Saksena S, Onyuksel H (2017) GLP-1 nanomedicine alleviates gut inflammation. Nanomedicine: Nanotechnology. Biology and Medicine 13:659\u2013665","journal-title":"Biology and Medicine"},{"key":"3631_CR8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.nano.2016.08.004","volume":"13","author":"AN Anbazhagan","year":"2017","unstructured":"Anbazhagan AN, Thaqi M, Priyamvada S, Jayawardena D, Kumar A, Gujral T, Chatterjee I, Mugarza E, Saksena S, Onyuksel H, Dudeja PK (2017) GLP-1 nanomedicine alleviates gut inflammation. Nanomedicine 13:659\u2013665","journal-title":"Nanomedicine"},{"key":"3631_CR9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","volume":"14","author":"A Andersen","year":"2018","unstructured":"Andersen A, Lund A, Knop FK, Vilsb\u00f8ll T (2018) Glucagon-like peptide 1 in health and disease. Nat Rev Endocrinol 14:390\u2013403","journal-title":"Nat Rev Endocrinol"},{"key":"3631_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/life11030195","volume":"11","author":"MN Ansari","year":"2021","unstructured":"Ansari MN, Rehman NU, Karim A, Soliman GA, Ganaie MA, Raish M, Hamad AM (2021) Role of oxidative stress and inflammatory cytokines (Tnf-\u03b1 and il-6) in acetic acid-induced ulcerative colitis in rats: ameliorated by otostegia fruticosa. Life 11:195","journal-title":"Life"},{"key":"3631_CR11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/1440-1681.13361","volume":"47","author":"O Azmy Nabeh","year":"2020","unstructured":"Azmy Nabeh O, Ishak Attallah M, El-Sayed El-Gawhary N (2020) The pivotal relation between glucagon-like peptides, NF\u03baB and inflammatory bowel disease. Clin Exp Pharmacol Physiol 47:1641\u20131648","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3631_CR12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/19390211.2018.1470128","volume":"16","author":"S Babitha","year":"2019","unstructured":"Babitha S, Bindu K, Nageena T, Veerapur V (2019) Fresh fruit juice of Opuntia dillenii Haw. attenuates acetic acid\u2013induced ulcerative colitis in rats. J Diet Suppl 16:431\u2013442","journal-title":"J Diet Suppl"},{"key":"3631_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1319-3767.173753","volume":"22","author":"IM Balmus","year":"2016","unstructured":"Balmus IM, Ciobica A, Trifan A, Stanciu C (2016) The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc 22:3","journal-title":"Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc"},{"key":"3631_CR14","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1002\/jcp.27823","volume":"234","author":"MM Binabaj","year":"2019","unstructured":"Binabaj MM, Asgharzadeh F, Avan A, Rahmani F, Soleimani A, Parizadeh MR, Ferns GA, Ryzhikov M, Khazaei M, Hassanian SM (2019) EW-7197 prevents ulcerative colitis-associated fibrosis and inflammation. J Cell Physiol 234:11654\u201311661","journal-title":"J Cell Physiol"},{"key":"3631_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-016-0676-y","volume":"77","author":"P Boal Carvalho","year":"2017","unstructured":"Boal Carvalho P, Cotter J (2017) Mucosal healing in ulcerative colitis: a comprehensive review. Drugs 77:159\u2013173","journal-title":"Drugs"},{"key":"3631_CR16","doi-asserted-by":"crossref","first-page":"e54543","DOI":"10.1371\/journal.pone.0054543","volume":"8","author":"\u00d8 Brenna","year":"2013","unstructured":"Brenna \u00d8, Furnes M, Drozdov I, van Beelen GA, Flatberg A, Sandvik A, Zwiggelaar R, M\u00e5rvik R, Nordrum I (2013) Kidd MJPo Correction: Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Histologic and Transcriptomic Characterization and Correlation to IBD. PLoS One 8:e54543","journal-title":"PLoS One"},{"key":"3631_CR17","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.3892\/etm.2016.3728","volume":"12","author":"YF Cagin","year":"2016","unstructured":"Cagin YF, Parlakpinar H, Vardi N, Polat A, Atayan Y, Erdogan MA, Tanbek K (2016) Effects of dexpanthenol on acetic acid-induced colitis in rats. Exp Ther Med 12:2958\u20132964","journal-title":"Exp Ther Med"},{"key":"3631_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1620\/tjem.206.131","volume":"206","author":"A Cetinkaya","year":"2005","unstructured":"Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA (2005) Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Tohoku J Exp Med 206:131\u2013139","journal-title":"Tohoku J Exp Med"},{"key":"3631_CR19","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ijms20071584","volume":"20","author":"H-YC Chiou","year":"2019","unstructured":"Chiou H-YC, Lin M-W, Hsiao P-J, Chen C-L, Chiao S, Lin T-Y, Chen Y-C, Wu D-C, Lin M-H (2019) Dulaglutide modulates the development of tissue-infiltrating Th1\/Th17 cells and the pathogenicity of encephalitogenic Th1 cells in the central nervous system. Int J Mol Sci 20:1584","journal-title":"Int J Mol Sci"},{"key":"3631_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01179-1","volume":"19","author":"GR Dagenais","year":"2020","unstructured":"Dagenais GR, Ryd\u00e9n L, Leiter LA, Lakshmanan M, Dyal L, Probstfield JL, Atisso CM, Shaw JE, Conget I, Cushman WC (2020) Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis. Cardiovasc Diabetol 19:1\u20138","journal-title":"Cardiovasc Diabetol"},{"key":"3631_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharep.2013.08.013","volume":"66","author":"D Dodda","year":"2014","unstructured":"Dodda D, Chhajed R, Mishra J (2014) Protective effect of quercetin against acetic acid induced inflammatory bowel disease (IBD) like symptoms in rats: possible morphological and biochemical alterations. Pharmacol Rep 66:169\u2013173","journal-title":"Pharmacol Rep"},{"key":"3631_CR22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(14)60976-4","volume":"384","author":"KM Dungan","year":"2014","unstructured":"Dungan KM, Povedano ST, Forst T, Gonz\u00e1lez JGG, Atisso C, Sealls W, Fahrbach JL (2014) Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial. The Lancet 384:1349\u20131357","journal-title":"The Lancet"},{"key":"3631_CR23","doi-asserted-by":"crossref","first-page":"121820","DOI":"10.1016\/j.lfs.2023.121820","volume":"327","author":"RN El Mahdy","year":"2023","unstructured":"El Mahdy RN, Nader MA, Helal MG, Abu-Risha SE, Abdelmageed ME (2023) Eicosapentaenoic acid mitigates ulcerative colitis-induced by acetic acid through modulation of NF-\u03baB and TGF-\u03b2\/EGFR signaling pathways. Life Sci 327:121820","journal-title":"Life Sci"},{"key":"3631_CR24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopha.2019.01.001","volume":"111","author":"G El-Akabawy","year":"2019","unstructured":"El-Akabawy G, El-Sherif NM (2019) Zeaxanthin exerts protective effects on acetic acid-induced colitis in rats via modulation of pro-inflammatory cytokines and oxidative stress. Biomed Pharmacother 111:841\u2013851","journal-title":"Biomed Pharmacother"},{"key":"3631_CR25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopha.2019.01.001","volume":"111","author":"G El-Akabawy","year":"2019","unstructured":"El-Akabawy G, El-Sherif NM (2019) Zeaxanthin exerts protective effects on acetic acid-induced colitis in rats via modulation of pro-inflammatory cytokines and oxidative stress. Biomed Pharmacother 111:841\u2013851","journal-title":"Biomed Pharmacother"},{"key":"3631_CR26","doi-asserted-by":"crossref","first-page":"173234","DOI":"10.1016\/j.ejphar.2020.173234","volume":"881","author":"SM Elshazly","year":"2020","unstructured":"Elshazly SM, Elhassanny AE, Mahmoud NM (2020) Cilostazol protects against acetic acid-induced colitis in rats: possible role for cAMP\/SIRT1 pathway. Eur J Pharmacol 881:173234","journal-title":"Eur J Pharmacol"},{"key":"3631_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21608\/ajps.2020.86014","volume":"61","author":"O Farghaly","year":"2020","unstructured":"Farghaly O (2020) Experimental ulcerative colitis: TGF-\u0392 as a diagnostic marker. Al-Azhar J Pharm Sci 61:46\u201360","journal-title":"Al-Azhar J Pharm Sci"},{"key":"3631_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2017.03.038","volume":"90","author":"M Ghasemi-Pirbaluti","year":"2017","unstructured":"Ghasemi-Pirbaluti M, Motaghi E, Najafi A, Hosseini MJ (2017) The effect of theophylline on acetic acid induced ulcerative colitis in rats. Biomed Pharmacother 90:153\u2013159","journal-title":"Biomed Pharmacother"},{"key":"3631_CR29","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/27.8.90074","volume":"27","author":"J-L Guesdon","year":"1979","unstructured":"Guesdon J-L, Ternynck T, Avrameas S (1979) The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131\u20131139","journal-title":"J Histochem Cytochem"},{"key":"3631_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.dsx.2016.09.003","volume":"11","author":"A Gupta","year":"2017","unstructured":"Gupta A, Jelinek HF, Al-Aubaidy H (2017) Glucagon like peptide-1 and its receptor agonists: their roles in management of type 2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev 11:225\u2013230","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"3631_CR31","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1074\/jbc.M306976200","volume":"279","author":"JA Gustin","year":"2004","unstructured":"Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase\/Akt signaling to NF-kappa B activation. J Biol Chem 279:1615\u20131620","journal-title":"J Biol Chem"},{"key":"3631_CR32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-011-0325-6","volume":"60","author":"XL Huang","year":"2011","unstructured":"Huang XL, Xu J, Zhang XH, Qiu BY, Peng L, Zhang M, Gan HT (2011) PI3K\/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. Inflamm Res 60:727\u2013734","journal-title":"Inflamm Res"},{"key":"3631_CR33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/biomedicines9040383","volume":"9","author":"JE Hunt","year":"2021","unstructured":"Hunt JE, Holst JJ, Jeppesen PB, Kissow H (2021) GLP-1 and Intestinal Diseases. Biomedicines 9:383","journal-title":"Biomedicines"},{"key":"3631_CR34","doi-asserted-by":"crossref","first-page":"106610","DOI":"10.1016\/j.intimp.2020.106610","volume":"85","author":"S Ibrahim","year":"2020","unstructured":"Ibrahim S, Zhu X, Luo X, Feng Y, Wang J (2020) PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel disease. Int Immunopharmacol 85:106610","journal-title":"Int Immunopharmacol"},{"key":"3631_CR35","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/cti.2015.47","volume":"5","author":"Y Ilan","year":"2016","unstructured":"Ilan Y (2016) Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease. Clin Trans immunol 5:e60","journal-title":"Clin Trans immunol"},{"key":"3631_CR36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","volume":"55","author":"T Iwai","year":"2006","unstructured":"Iwai T, Ito S, Tanimitsu K, Udagawa S, Oka J-I (2006) Glucagon-like peptide-1 inhibits LPS-induced IL-1\u03b2 production in cultured rat astrocytes. Neurosci Res 55:352\u2013360","journal-title":"Neurosci Res"},{"key":"3631_CR37","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.3390\/ijms23115929","volume":"23","author":"H Jang","year":"2022","unstructured":"Jang H, Kim S, Kim H, Oh SH, Kwak SY, Joo HW, Lee SB, Jang WI, Park S, Shim S (2022) Metformin protects the intestinal barrier by activating goblet cell maturation and epithelial proliferation in radiation-induced enteropathy. Int J Mol Sci 23:5929","journal-title":"Int J Mol Sci"},{"key":"3631_CR38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1515\/sjecr-2017-0019","volume":"19","author":"M Jovanovic","year":"2017","unstructured":"Jovanovic M, Zdravkovic N, Jovanovic I, Radosavljevic G, Gajovic N, Zdravkovic N, Maric V, Arsenijevic N (2017) TGF-\u03b2 as a marker of ulcerative colitis and disease severity. Serbian J Exp Clin Res 19:229\u2013236","journal-title":"Serbian J Exp Clin Res"},{"key":"3631_CR39","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2012-303280","volume":"62","author":"H Kissow","year":"2013","unstructured":"Kissow H, Hartmann B, Holst JJ, Poulsen SS (2013) Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis. Gut 62:1724\u20131733","journal-title":"Gut"},{"key":"3631_CR40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2015.02.005","volume":"21","author":"JA Koehler","year":"2015","unstructured":"Koehler JA, Baggio LL, Yusta B, Longuet C, Rowland KJ, Cao X, Holland D, Brubaker PL, Drucker DJ (2015) GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7. Cell Metabolism 21:379\u2013391","journal-title":"Cell Metabolism"},{"key":"3631_CR41","doi-asserted-by":"crossref","first-page":"e97554","DOI":"10.1371\/journal.pone.0097554","volume":"9","author":"NM Krasner","year":"2014","unstructured":"Krasner NM, Ido Y, Ruderman NB, Cacicedo JM (2014) Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism. PLoS One 9:e97554","journal-title":"PLoS One"},{"key":"3631_CR42","first-page":"3094642","volume":"2016","author":"YS Lee","year":"2016","unstructured":"Lee YS, Jun HS (2016) Anti-inflammatory effects of GLP-1-based therapies beyond glucose control. Mediat Inflamm 2016:3094642","journal-title":"Mediat Inflamm"},{"key":"3631_CR43","doi-asserted-by":"crossref","first-page":"108968","DOI":"10.1016\/j.cbi.2020.108968","volume":"322","author":"H Li","year":"2020","unstructured":"Li H, Chen J, Li B, Fang X (2020) The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type collagen and aggrecan in human SW1353 chondrocytes. Chemico-Biol Int 322:108968","journal-title":"Chemico-Biol Int"},{"key":"3631_CR44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/jnc.15521","volume":"159","author":"Y Li","year":"2021","unstructured":"Li Y, Glotfelty EJ, Karlsson T, Fortuno LV, Harvey BK, Greig NH (2021) The metabolite GLP-1 (9\u201336) is neuroprotective and anti-inflammatory in cellular models of neurodegeneration. J Neurochem 159:867\u2013886","journal-title":"J Neurochem"},{"key":"3631_CR45","doi-asserted-by":"crossref","first-page":"170481","DOI":"10.1016\/j.peptides.2020.170481","volume":"137","author":"X-l Ma","year":"2021","unstructured":"Ma X-l, Ding Y, Wu L-M, Wang Y-X, Yao Y, Wang Y-X, Zhang Y-G, Niu J-Q, He X-X, Wang Y-Q (2021) The glucagon-like peptide-1 (GLP-1) analog exenatide ameliorates intrauterine adhesions in mice. Peptides 137:170481","journal-title":"Peptides"},{"key":"3631_CR46","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2174\/13894501113149990157","volume":"14","author":"I Marafini","year":"2013","unstructured":"Marafini I, Zorzi F, Codazza S, Pallone F, Monteleone G (2013) TGF-beta signaling manipulation as potential therapy for IBD. Curr Drug Targ 14:1400\u20131404","journal-title":"Curr Drug Targ"},{"key":"3631_CR47","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jep.2013.10.006","volume":"150","author":"LP Mazzolin","year":"2013","unstructured":"Mazzolin LP, de Almeida Kiguti LR, da Maia EO, Fernandes LTL, da Rocha LRM, Vilegas W, Pupo AS, Di Stasi LC, Hiruma-Lima CA (2013) Antidiarrheal and intestinal antiinflammatory activities of a methanolic extract of Qualea parviflora Mart. in experimental models. J Ethnopharmacol 150:1016\u20131023","journal-title":"J Ethnopharmacol"},{"key":"3631_CR48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/pgmj.2004.030817","volume":"81","author":"Q Mei","year":"2005","unstructured":"Mei Q, Xu J, Xiang L, Hu Y, Hu X, Xu Z (2005) Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad Med J 81:667\u2013672","journal-title":"Postgrad Med J"},{"key":"3631_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.2003.02268.x","volume":"134","author":"S Melgar","year":"2003","unstructured":"Melgar S, Yeung MM, Bas A, Forsberg G, Suhr O, \u00d6berg \u00c5, Hammarstr\u00f6m S, Danielsson \u00c5, Hammarstr\u00f6m M-L (2003) Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol 134:127\u2013137","journal-title":"Clin Exp Immunol"},{"key":"3631_CR50","doi-asserted-by":"crossref","first-page":"628157","DOI":"10.1155\/2015\/628157","volume":"2015","author":"A Michielan","year":"2015","unstructured":"Michielan A, D\u2019Inc\u00e0 R (2015) Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediat Inflamm 2015:628157","journal-title":"Mediat Inflamm"},{"key":"3631_CR51","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","volume":"61","author":"MF Neurath","year":"2012","unstructured":"Neurath MF, Travis SP (2012) Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 61:1619\u20131635","journal-title":"Gut"},{"key":"3631_CR52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fphar.2020.00090","volume":"11","author":"TTN Nguyen","year":"2020","unstructured":"Nguyen TTN, Choi H, Jun H-S (2020) Preventive effects of dulaglutide on disuse muscle atrophy through inhibition of inflammation and apoptosis by induction of Hsp72 expression. Front Pharmacol 11:90","journal-title":"Front Pharmacol"},{"key":"3631_CR53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"3631_CR54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jep.2013.10.056","volume":"151","author":"PR Orsi","year":"2014","unstructured":"Orsi PR, Seito LN, Di Stasi LC (2014) Hymenaea stigonocarpa Mart. ex Hayne: A tropical medicinal plant with intestinal anti-inflammatory activity in TNBS model of intestinal inflammation in rats. J Ethnopharmacol 151:380\u2013385","journal-title":"J Ethnopharmacol"},{"key":"3631_CR55","doi-asserted-by":"crossref","first-page":"15601","DOI":"10.1038\/s41598-019-51648-1","volume":"9","author":"HJ Park","year":"2019","unstructured":"Park HJ, Han H, Oh EY, Kim SR, Park KH, Lee JH, Park JW (2019) Empagliflozin and dulaglutide are effective against obesity-induced airway hyperresponsiveness and fibrosis in a murine model. Sci Rep 9:15601","journal-title":"Sci Rep"},{"key":"3631_CR56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.gastro.2009.03.007","volume":"137","author":"DK Podolsky","year":"2009","unstructured":"Podolsky DK, Gerken G, Eyking A, Cario E (2009) Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137:209\u2013220","journal-title":"Gastroenterology"},{"key":"3631_CR57","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","volume":"3","author":"G Rakipovski","year":"2018","unstructured":"Rakipovski G, Rolin B, N\u00f8hr J, Klewe I, Frederiksen KS, Augustin R, Hecksher-S\u00f8rensen J, Ingvorsen C, Polex-Wolf J, Knudsen LB (2018) The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(-\/-) and LDLr(-\/-) Mice by a Mechanism That Includes Inflammatory Pathways. JACC Basic Transl Sci 3:844\u2013857","journal-title":"JACC Basic Transl Sci"},{"key":"3631_CR58","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/j.1460-2075.1991.tb07761.x","volume":"10","author":"R Schreck","year":"1991","unstructured":"Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. The EMBO J 10:2247\u20132258","journal-title":"The EMBO J"},{"key":"3631_CR59","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.3390\/molecules27134139","volume":"27","author":"M Shahid","year":"2022","unstructured":"Shahid M, Raish M, Ahmad A, Bin Jardan YA, Ansari MA, Ahad A, Alkharfy KM, Alaofi AL, Al-Jenoobi FI (2022) Sinapic acid ameliorates acetic acid-induced ulcerative colitis in rats by suppressing inflammation, oxidative stress, and apoptosis. Molecules 27:4139","journal-title":"Molecules"},{"key":"3631_CR60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cbi.2018.11.002","volume":"298","author":"NA Soliman","year":"2019","unstructured":"Soliman NA, Keshk WA, Rizk FH, Ibrahim MA (2019) The possible ameliorative effect of simvastatin versus sulfasalazine on acetic acid induced ulcerative colitis in adult rats. Chem Biol Interact 298:57\u201365","journal-title":"Chem Biol Interact"},{"key":"3631_CR61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/pgmj.2005.037945","volume":"82","author":"M Song","year":"2006","unstructured":"Song M, Xia B, Li J (2006) Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgrad Med J 82:130\u2013135","journal-title":"Postgrad Med J"},{"key":"3631_CR62","doi-asserted-by":"crossref","first-page":"H2211","DOI":"10.1152\/ajpheart.00966.2011","volume":"302","author":"PA Suwanabol","year":"2012","unstructured":"Suwanabol PA, Seedial SM, Zhang F, Shi X, Si Y, Liu B, Kent KC (2012) TGF-\u03b2 and Smad3 modulate PI3K\/Akt signaling pathway in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 302:H2211-2219","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3631_CR63","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41398-020-00923-1","volume":"10","author":"D Vall\u00f6f","year":"2020","unstructured":"Vall\u00f6f D, Kalafateli AL, Jerlhag E (2020) Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats. Transl Psychiatry 10:238","journal-title":"Transl Psychiatry"},{"key":"3631_CR64","doi-asserted-by":"crossref","first-page":"e0142481","DOI":"10.1371\/journal.pone.0142481","volume":"11","author":"ME van der Valk","year":"2016","unstructured":"van der Valk ME, Mangen MJ, Severs M, van der Have M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, van de Meeberg PC, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk C, Vermeijden JR, Siersema PD, Leenders M, Oldenburg B (2016) Evolution of costs of inflammatory bowel disease over two years of follow-up. PLoS One 11:e0142481","journal-title":"PLoS One"},{"key":"3631_CR65","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3748\/wjg.v16.i18.2252","volume":"16","author":"K Wang","year":"2010","unstructured":"Wang K, Yuan C-P, Wang W, Yang Z-Q, Cui W, Mu L-Z, Yue Z-P, Yin X-L, Hu Z-M, Liu J-X (2010) Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis. World J Gastroenterol WJG 16:2252","journal-title":"World J Gastroenterol WJG"},{"key":"3631_CR66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2018.03.009","volume":"142","author":"RF Wang","year":"2018","unstructured":"Wang RF, Xue GF, H\u00f6lscher C, Tian MJ, Feng P, Zheng JY, Li DF (2018) Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus. Epilepsy Res 142:45\u201352","journal-title":"Epilepsy Res"},{"key":"3631_CR67","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/acsomega.0c06326","volume":"6","author":"R Wang","year":"2021","unstructured":"Wang R, Wang N, Han Y, Xu J, Xu Z (2021) Dulaglutide alleviates LPS-induced injury in cardiomyocytes. ACS Omega 6:8271\u20138278","journal-title":"ACS Omega"},{"key":"3631_CR68","doi-asserted-by":"crossref","first-page":"170624","DOI":"10.1016\/j.peptides.2021.170624","volume":"145","author":"L-m Wu","year":"2021","unstructured":"Wu L-m, Wang Y-x, Zhan Y, Liu A-h, Wang Y-x, Shen H-f, Wang Y-f, Wang L-y, Tao Z-b, Wang Y-q (2021) Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats. Peptides 145:170624","journal-title":"Peptides"},{"key":"3631_CR69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427\u2013434","journal-title":"Nature"},{"key":"3631_CR70","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12933-022-01634-1","volume":"21","author":"D Xie","year":"2022","unstructured":"Xie D, Li Y, Xu M, Zhao X, Chen M (2022) Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 21:200","journal-title":"Cardiovasc Diabetol"},{"key":"3631_CR71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41374-018-0170-0","volume":"99","author":"J Xu","year":"2019","unstructured":"Xu J, Wei G, Wang J, Zhu J, Yu M, Zeng X, Wang H, Xie W, Kong H (2019) Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function. Lab Invest 99:577\u2013587","journal-title":"Lab Invest"},{"key":"3631_CR72","first-page":"4621131","volume":"2022","author":"Z Xu","year":"2022","unstructured":"Xu Z, Zhang X, Lu R, Zhang D, Zou T, Chen M, Zhang D (2022) Mechanism of fructus mume pills underlying their protective effects in rats with acetic acid-inducedulcerative colitis via the regulation of inflammatory cytokines and the VEGF-PI3K\/Akt-eNOS signaling pathway. Evid Based Complement Alternat Med 2022:4621131","journal-title":"Evid Based Complement Alternat Med"},{"key":"3631_CR73","doi-asserted-by":"crossref","first-page":"118645","DOI":"10.1016\/j.lfs.2020.118645","volume":"264","author":"H Yaribeygi","year":"2021","unstructured":"Yaribeygi H, Rashidy-Pour A, Atkin SL, Jamialahmadi T, Sahebkar A (2021) GLP-1 mimetics and cognition. Life Sci 264:118645","journal-title":"Life Sci"},{"key":"3631_CR74","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/db14-1577","volume":"64","author":"B Yusta","year":"2015","unstructured":"Yusta B, Baggio LL, Koehler J, Holland D, Cao X, Pinnell LJ, Johnson-Henry KC, Yeung W, Surette MG, Bang KA (2015) GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R. Diabetes 64:2537\u20132549","journal-title":"Diabetes"},{"key":"3631_CR75","doi-asserted-by":"crossref","first-page":"103833","DOI":"10.1016\/j.etap.2022.103833","volume":"91","author":"MS Zaghloul","year":"2022","unstructured":"Zaghloul MS, Elshal M, Abdelmageed ME (2022) Preventive empagliflozin activity on acute acetic acid-induced ulcerative colitis in rats via modulation of SIRT-1\/PI3K\/AKT pathway and improving colon barrier. Environ Toxicol Pharmacol 91:103833","journal-title":"Environ Toxicol Pharmacol"},{"key":"3631_CR76","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00210-019-01698-z","volume":"392","author":"H Zatorski","year":"2019","unstructured":"Zatorski H, Sa\u0142aga M, Fichna J (2019) Role of glucagon-like peptides in inflammatory bowel diseases\u2014current knowledge and future perspectives. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 392:1321\u20131330","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"3631_CR77","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1007\/s43440-021-00327-y","volume":"73","author":"H Zatorski","year":"2021","unstructured":"Zatorski H, Salaga M, Zieli\u0144ska M, Mokrowiecka A, Jacenik D, Krajewska WM, Ma\u0142ecka-Panas E, Fichna J (2021) Colonic inflammation induces changes in glucose levels through modulation of incretin system. Pharmacol Rep 73:1670\u20131679","journal-title":"Pharmacol Rep"},{"key":"3631_CR78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE (2009) Non-Smad pathways in TGF-\u03b2 signaling. Cell Res 19:128\u2013139","journal-title":"Cell Res"},{"key":"3631_CR79","doi-asserted-by":"crossref","first-page":"105649","DOI":"10.1016\/j.intimp.2019.05.034","volume":"74","author":"W Zheng","year":"2019","unstructured":"Zheng W, Pan H, Wei L, Gao F, Lin X (2019) Dulaglutide mitigates inflammatory response in fibroblast-like synoviocytes. Int Immunopharmacol 74:105649","journal-title":"Int Immunopharmacol"},{"key":"3631_CR80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000475731","volume":"32","author":"T Zietek","year":"2017","unstructured":"Zietek T, Waldschmitt N, Rath E (2017) Role of incretin hormones in bowel diseases. Dev Biol Gastrointest Hormones 32:49\u201373","journal-title":"Dev Biol Gastrointest Hormones"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03631-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:19:03Z","timestamp":1744258743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03631-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3631"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03631-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}